Suministro de medicamentos citostáticos parenterales con principios activos cabazitaxel, trióxido de arsénico, paclitaxel, paclitaxel-albúmina, bendamustina, bortezomib, busulfan, carboplatino, cisplatino, doxorubicina, etoposido, fludarabina, gemcitabina, irinotecan, vinorelbina y ciclofosfamida .

Contract type	Supplies
CPV	33652100
Deadline	27 June 2025

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.